Search results
Results from the WOW.Com Content Network
The biotech industry has lagged the broader market so far in 2024. The SPDR S&P Biotech ETF, an industry benchmark, is up 9% this year compared to 28% for the S&P 500. Will that trend continue in ...
When the company reported VK2735's phase 2 results last year, the stock jumped 121% in one trading session. Viking gave back some of those gains, but still finished the year, as mentioned above ...
Top 9 Biotech ETFs for 2024 When assessing all angles of an investment, you want to make sure your money will be working for you, or at least predicted to do so. Here are a few recommendations for ...
The Best Biotech Stock to Invest $1,000 in Right Now. ... That outcome would likely turn an investment of $1,000 into $2,000 or more in short order. ... *Stock Advisor returns as of June 10, 2024.
These longtime leading biotech stocks still have plenty of ... 2024 at 10:15 AM ... revenue increased by 6% year over year to $2.65 billion. And Vertex's top line will start growing faster soon ...
With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an impressive resume already, but it's just getting started. It's currently in the ...
Here are three no-brainer biotech stocks to buy with $200 right now. Biotech stocks usually appeal more to aggressive growth investors, while value investors typically prefer to look elsewhere.
In the third quarter, the company's revenue of $2.77 billion increased by 12% year over year, a strong performance for a biotech giant. The company's best CF treatment yet, Trikafta, accounted for ...